MetLife Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $76.1K | Buy |
+67,990
| New | +$76.1K | ﹤0.01% | 2653 |
|
2025
Q1 | – | Sell |
-16,641
| Closed | -$27.5K | – | 2794 |
|
2024
Q4 | $27.5K | Sell |
16,641
-26,011
| -61% | -$42.9K | ﹤0.01% | 2781 |
|
2024
Q3 | $149K | Sell |
42,652
-17,337
| -29% | -$60.7K | ﹤0.01% | 2437 |
|
2024
Q2 | $197K | Buy |
59,989
+21,660
| +57% | +$71K | ﹤0.01% | 2253 |
|
2024
Q1 | $281K | Sell |
38,329
-5,675
| -13% | -$41.7K | ﹤0.01% | 1994 |
|
2023
Q4 | $165K | Hold |
44,004
| – | – | ﹤0.01% | 2345 |
|
2023
Q3 | $93.3K | Hold |
44,004
| – | – | ﹤0.01% | 2615 |
|
2023
Q2 | $209K | Hold |
44,004
| – | – | ﹤0.01% | 2248 |
|
2023
Q1 | $251K | Hold |
44,004
| – | – | ﹤0.01% | 2084 |
|
2022
Q4 | $444K | Hold |
44,004
| – | – | ﹤0.01% | 1713 |
|
2022
Q3 | $986K | Hold |
44,004
| – | – | 0.01% | 1198 |
|
2022
Q2 | $1.09M | Hold |
44,004
| – | – | 0.01% | 1168 |
|
2022
Q1 | $1.71M | Buy |
44,004
+15,638
| +55% | +$606K | 0.01% | 1062 |
|
2021
Q4 | $1.66M | Hold |
28,366
| – | – | 0.01% | 932 |
|
2021
Q3 | $1.68M | Hold |
28,366
| – | – | 0.02% | 927 |
|
2021
Q2 | $2.46M | Hold |
28,366
| – | – | 0.02% | 779 |
|
2021
Q1 | $2.34M | Sell |
28,366
-210
| -0.7% | -$17.3K | 0.02% | 809 |
|
2020
Q4 | $2.6M | Sell |
28,576
-1,683
| -6% | -$153K | 0.02% | 704 |
|
2020
Q3 | $1.21M | Buy |
30,259
+3,344
| +12% | +$134K | 0.01% | 941 |
|
2020
Q2 | $923K | Hold |
26,915
| – | – | 0.01% | 1070 |
|
2020
Q1 | $598K | Hold |
26,915
| – | – | 0.01% | 1121 |
|
2019
Q4 | $527K | Buy |
26,915
+3,655
| +16% | +$71.5K | 0.01% | 1437 |
|
2019
Q3 | $361K | Sell |
23,260
-4,623
| -17% | -$71.8K | ﹤0.01% | 1590 |
|
2019
Q2 | $566K | Hold |
27,883
| – | – | 0.01% | 1404 |
|
2019
Q1 | $490K | Hold |
27,883
| – | – | 0.01% | 1465 |
|
2018
Q4 | $358K | Buy |
27,883
+4,805
| +21% | +$61.6K | ﹤0.01% | 1567 |
|
2018
Q3 | $376K | Hold |
23,078
| – | – | ﹤0.01% | 1716 |
|
2018
Q2 | $262K | Hold |
23,078
| – | – | ﹤0.01% | 1783 |
|
2018
Q1 | $225K | Buy |
+23,078
| New | +$225K | ﹤0.01% | 1823 |
|